Ovarian Cancer Drugs Market Report

Global and Region Ovarian Cancer Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：169
  • REPORT CODE：GMM991961
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Ovarian cancer is regarded as one of the most common types of cancer among women. It accounts for more deaths than any other cancer of the female reproductive system, while it ranks 5th in overall women deaths due to cancer. This type of cancer is rarely diagnosed at an early stage, making treatment at an advanced stage difficult.

    The report details the trend, potential and market size of Ovarian Cancer Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Ovarian Cancer Drugsmarket, defines the market attractiveness level of Ovarian Cancer Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Ovarian Cancer Drugs industry, describes the types of Ovarian Cancer Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Ovarian Cancer Drugs market and the development prospects and opportunities of Ovarian Cancer Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Ovarian Cancer Drugs market in Chapter 13.

    By Player:

    • Allergan plc

    • F Hoffmann-La Roche AG

    • AstraZeneca

    • Clovis Oncology

    • Pfizer, Inc

    • Johnson & Johnson

    • Merck KGaA

    • Syndax Pharmaceuticals, Inc

    By Type:

    • Alkylating Agents

    • Mitotic Inhibitors

    • Antirheumatics

    • Antipsoriatics

    • VEGF/VEGFR Inhibitors

    • PARP Inhibitors

    • Antineoplastics

    • Others

    By End-User:

    • Hospital Pharmacies

    • Drug Stores

    • Online Pharmacies

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Ovarian Cancer Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Ovarian Cancer Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Ovarian Cancer Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Ovarian Cancer Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Ovarian Cancer Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Ovarian Cancer Drugs Consumption (2017-2022)

    • 7.2 United States Ovarian Cancer Drugs Consumption (2017-2022)

    • 7.3 Europe Ovarian Cancer Drugs Consumption (2017-2022)

    • 7.4 China Ovarian Cancer Drugs Consumption (2017-2022)

    • 7.5 Japan Ovarian Cancer Drugs Consumption (2017-2022)

    • 7.6 India Ovarian Cancer Drugs Consumption (2017-2022)

    • 7.7 South Korea Ovarian Cancer Drugs Consumption (2017-2022)

    8 Region and Country-wise Ovarian Cancer Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Ovarian Cancer Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Ovarian Cancer Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Ovarian Cancer Drugs Consumption Forecast (2022-2028)

    • 8.4 China Ovarian Cancer Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Ovarian Cancer Drugs Consumption Forecast (2022-2028)

    • 8.6 India Ovarian Cancer Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Ovarian Cancer Drugs Consumption Forecast (2022-2028)

    9 Global Ovarian Cancer Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Ovarian Cancer Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Alkylating Agents Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Mitotic Inhibitors Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Antirheumatics Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Antipsoriatics Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global VEGF/VEGFR Inhibitors Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global PARP Inhibitors Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Antineoplastics Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Ovarian Cancer Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Drug Stores Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Ovarian Cancer Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Ovarian Cancer Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Alkylating Agents Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Mitotic Inhibitors Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Antirheumatics Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Antipsoriatics Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global VEGF/VEGFR Inhibitors Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global PARP Inhibitors Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Antineoplastics Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.8 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Ovarian Cancer Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Ovarian Cancer Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Ovarian Cancer Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Ovarian Cancer Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Ovarian Cancer Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Ovarian Cancer Drugs Market Competitive Analysis

    • 14.1 Allergan plc

      • 14.1.1 Allergan plc Company Details

      • 14.1.2 Allergan plc Ovarian Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Allergan plc Ovarian Cancer Drugs Product and Service

    • 14.2 F Hoffmann-La Roche AG

      • 14.2.1 F Hoffmann-La Roche AG Company Details

      • 14.2.2 F Hoffmann-La Roche AG Ovarian Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 F Hoffmann-La Roche AG Ovarian Cancer Drugs Product and Service

    • 14.3 AstraZeneca

      • 14.3.1 AstraZeneca Company Details

      • 14.3.2 AstraZeneca Ovarian Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 AstraZeneca Ovarian Cancer Drugs Product and Service

    • 14.4 Clovis Oncology

      • 14.4.1 Clovis Oncology Company Details

      • 14.4.2 Clovis Oncology Ovarian Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Clovis Oncology Ovarian Cancer Drugs Product and Service

    • 14.5 Pfizer, Inc

      • 14.5.1 Pfizer, Inc Company Details

      • 14.5.2 Pfizer, Inc Ovarian Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Pfizer, Inc Ovarian Cancer Drugs Product and Service

    • 14.6 Johnson & Johnson

      • 14.6.1 Johnson & Johnson Company Details

      • 14.6.2 Johnson & Johnson Ovarian Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Johnson & Johnson Ovarian Cancer Drugs Product and Service

    • 14.7 Merck KGaA

      • 14.7.1 Merck KGaA Company Details

      • 14.7.2 Merck KGaA Ovarian Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Merck KGaA Ovarian Cancer Drugs Product and Service

    • 14.8 Syndax Pharmaceuticals, Inc

      • 14.8.1 Syndax Pharmaceuticals, Inc Company Details

      • 14.8.2 Syndax Pharmaceuticals, Inc Ovarian Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Syndax Pharmaceuticals, Inc Ovarian Cancer Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Ovarian Cancer Drugs

    • Figure Ovarian Cancer Drugs Picture

    • Table Global Ovarian Cancer Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Ovarian Cancer Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Ovarian Cancer Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Ovarian Cancer Drugs Consumption by Country (2017-2022)

    • Figure United States Ovarian Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Ovarian Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Ovarian Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Ovarian Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Ovarian Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Ovarian Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Ovarian Cancer Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Ovarian Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Ovarian Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Ovarian Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Ovarian Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Ovarian Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Ovarian Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Alkylating Agents Consumption and Growth Rate (2017-2022)

    • Figure Global Mitotic Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Global Antirheumatics Consumption and Growth Rate (2017-2022)

    • Figure Global Antipsoriatics Consumption and Growth Rate (2017-2022)

    • Figure Global VEGF/VEGFR Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Global PARP Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Global Antineoplastics Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Drug Stores Consumption and Growth Rate (2017-2022)

    • Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Alkylating Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Mitotic Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antirheumatics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antipsoriatics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global VEGF/VEGFR Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global PARP Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antineoplastics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Ovarian Cancer Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Ovarian Cancer Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Allergan plc (Foundation Year, Company Profile and etc.)

    • Table Allergan plc Ovarian Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan plc Ovarian Cancer Drugs Product and Service

    • Table F Hoffmann-La Roche AG (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche AG Ovarian Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche AG Ovarian Cancer Drugs Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Ovarian Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Ovarian Cancer Drugs Product and Service

    • Table Clovis Oncology (Foundation Year, Company Profile and etc.)

    • Table Clovis Oncology Ovarian Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Clovis Oncology Ovarian Cancer Drugs Product and Service

    • Table Pfizer, Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer, Inc Ovarian Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer, Inc Ovarian Cancer Drugs Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Ovarian Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Ovarian Cancer Drugs Product and Service

    • Table Merck KGaA (Foundation Year, Company Profile and etc.)

    • Table Merck KGaA Ovarian Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck KGaA Ovarian Cancer Drugs Product and Service

    • Table Syndax Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Syndax Pharmaceuticals, Inc Ovarian Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Syndax Pharmaceuticals, Inc Ovarian Cancer Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US